We are tackling CF from all angles, so there are many different opportunities for your research to be part of the solution.
We offer awards for cystic fibrosis research and for professional development and training. Below is a list of current and upcoming funding opportunities.
The Cystic Fibrosis Foundation supports two programs that provide funds to biotechnology and pharmaceutical companies for development of new pharmaceutical products to benefit individuals with cystic fibrosis: The Therapeutics Development Award (TDA) and the Industry Award for Path to a Cure (PTAC) programs.
Learn how we fund research, how to navigate our grants management system as both an applicant and awardee, and key research priorities to keep in mind to maximize your potential for being funded.
Our research focuses on finding a cure, and until then, more effectively treating the most challenging complications of CF.
The journey to end cystic fibrosis isn't a straight line. It is an evolving map with many paths and unique challenges. It requires an ambitious research agenda to accelerate treatments and drug development for the underlying cause of the disease and ultimately deliver a cure.
The Cystic Fibrosis Foundation has committed at least $100 million from 2019-2023 to the Infection Research Initiative, a comprehensive effort to improve the detection, diagnosis, treatment, and outcomes of CF-related infections.
We support the development of many helpful tools and resources to assist you in accelerating the progress toward new scientific knowledge of and new therapies for cystic fibrosis.
Through collaboration rather than individual projects, we can make progress faster and better.
The TDN is the largest CF clinical trials network in the world. We bring together experts from across the country to evaluate the safety and effectiveness of new CF therapies through clinical studies.
These centers provide study sponsors and investigators centralized expertise in outcome measures for CF clinical research.
The STRC helps the clinical study of interventions so people with CF can more consistently manage their disease and improve health outcomes and quality of life.
This group brings together investigators who collaborate and share data to hasten the pace of CF-related stem cell research.
A group of care centers with expertise in NTM research and treatment conduct studies aiming to standardize the diagnosis and treatment of these bacterial infections.
These centers bring together leading scientists to pool their talents and advance understanding of the basic science of CF and the complex ways it affects different parts of the body.